For Ben Sasse, Revolution Medicines’ pancreatic cancer trial felt like his best, only option In Q&A, former senator discusses serious side effects but gains in ‘both quantity and quality of life’

https://www.statnews.com/2026/04/14/ben-sasse-revolution-medicines-daraxonrasib-clinical-trial/ By Angus ChenApril 14, 2026 Cancer Reporter